medicineBusinessPalantir’s Reputation Stalks Its Bid for the UK’s National Health DataBy Morgan Meaker and Grace BrowneBusinessThe Gruesome Story of How Neuralink’s Monkeys Actually DiedBy Dhruv Mehrotra and Dell CameronScienceEverything We Know About Neuralink’s Brain Implant TrialBy Emily MullinScienceHigh Blood Pressure Is the World’s Biggest Killer. Now There’s a Plan to Tackle ItBy Maryn McKennaScienceDeepMind’s New AI Can Predict Genetic DiseasesBy Amit KatwalaThe Big StoryCrispr Pioneer Jennifer Doudna Has the Guts to Take On the MicrobiomeBy Jennifer KahnScienceScientists Just Tried Growing Human Kidneys in PigsBy Emily MullinScienceOzempic and Wegovy Can Also Protect Your HeartBy Emily MullinCultureThe Aftermath of a 'Miracle Cure' for a Rare CancerBy James TaberyScienceA Brain Implant Helped Stroke Survivors Regain MovementBy Emily MullinThe Big StoryThe World Is Going Blind. Taiwan Offers a Warning, and a CureBy Amit KatwalaSecurityThe Plan to Better Protect US Hospitals From RansomwareBy Lily Hay NewmanBusinessHow Amazon’s In-House First Aid Clinics Push Injured Employees to Keep WorkingBy Caitlin HarringtonSecurityWhat Doctors Wish You Knew About HIPAA and Data SecurityBy Julie CharnetScienceA New Blood Test May Predict Your Alzheimer’s Risk. Should You Take It?By Emily MullinScienceEveryone Was Wrong About AntipsychoticsBy Max G. LevyIdeasChronic Illness TikTok Through the Eyes of a DoctorBy Nitin K. AhujaScienceThis Prosthetic Limb Actually Attaches to the Wearer’s NervesBy Maggie Chen ScienceA Patient May Be Free of HIV, Thanks to This DrugBy Emily MullinSciencePure Oxygen Helps People Learn Faster. Can It Help Stroke Patients Recover?By Celia FordBusinessDoctors on Bikes Prevented a Humanitarian Catastrophe in UkraineBy Johanna ChisholmScienceA Hair Loss Study Raises New Questions About Aging CellsBy Max G. LevyScienceA One-Time Shot for Type 2 Diabetes? A Biotech Company Is On ItBy Emily MullinScienceWhy People Stop Using Drugs Like OzempicBy Matt ReynoldsMore Stories
.jpg)
.jpg)
